I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Patients' Preferences for Adjuvant Osimertinib in Non–Small..:
Awidi, Muhammad
;
Mier-Hicks, Angel
;
Perimbeti, Stuthi
...
Clinical Lung Cancer. , 2024
Link:
https://doi.org/10.1016/j.cllc.2024.05.003
RT Journal T1
Patients' Preferences for Adjuvant Osimertinib in Non–Small-Cell Lung Cancer After Complete Surgical Resection: What Makes It Worth It to Patients?
UL https://suche.suub.uni-bremen.de/peid=cr-10.1016_j.cllc.2024.05.003&Exemplar=1&LAN=DE A1 Awidi, Muhammad A1 Mier-Hicks, Angel A1 Perimbeti, Stuthi A1 Attwood, Kristopher A1 Chen, Hongbin A1 Jain, Prantesh A1 Yau, Edwin A1 Early, Amy A1 Dy, Grace K. PB Elsevier BV YR 2024 SN 1525-7304 JF Clinical Lung Cancer LK http://dx.doi.org/https://doi.org/10.1016/j.cllc.2024.05.003 DO https://doi.org/10.1016/j.cllc.2024.05.003 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)